Nonproportional Hazards in Network Meta-Analysis: Efficient Strategies for Model Building and Analysis

被引:22
|
作者
Wiksten, Anna [1 ]
Hawkins, Neil [2 ]
Piepho, Hans-Peter [3 ]
Gsteiger, Sandro [4 ]
机构
[1] Novartis Pharma AG, Basel, Switzerland
[2] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland
[3] Univ Hohenheim, Biostat Unit, Stuttgart, Germany
[4] F Hoffmann La Roche & Cie AG, Basel, Switzerland
关键词
fractional polynomial models; network meta-analysis; nonproportional hazards time-to-event data; piecewise exponential models; CELL LUNG-CANCER; BETWEEN-STUDY HETEROGENEITY; PRIOR DISTRIBUTIONS; 2ND-LINE THERAPY; GEFITINIB IRESSA; SURVIVAL-DATA; OPEN-LABEL; DOCETAXEL;
D O I
10.1016/j.jval.2020.03.010
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: To develop efficient approaches for fitting network meta-analysis (NMA) models with time-varying hazard ratios (such as fractional polynomials and piecewise constant models) to allow practitioners to investigate a broad range of models rapidly and to achieve a more robust and comprehensive model selection strategy. Methods: We reformulated the fractional polynomial and piecewise constant NMA models using analysis of variance-like parameterization. With this approach, both models are expressed as generalized linear models (GLMs) with time-varying covariates. Such models can be fitted efficiently with standard frequentist techniques. We applied our approach to the example data from the study by Jansen et al, in which fractional polynomial NMA models were introduced. Results: Fitting frequentist fixed-effect NMAs for a large initial set of candidate models took less than 1 second with standard GLM routines. This allowed for model selection from a large range of hazard ratio structures by comparing a set of criteria including Akaike information criterion/Bayesian information criterion, visual inspection of goodness-of-fit, and long-term extrapolations. The "best" models were then refitted in a Bayesian framework. Estimates agreed very closely. Conclusions: NMA models with time-varying hazard ratios can be explored efficiently with a stepwise approach. A frequentist fixed-effect framework enables rapid exploration of different models. The best model can then be assessed further in a Bayesian framework to capture and propagate uncertainty for decision-making.
引用
收藏
页码:918 / 927
页数:10
相关论文
共 50 条
  • [1] NON-PROPORTIONAL HAZARDS IN NETWORK META-ANALYSIS: EFFICIENT STRATEGIES FOR MODEL BUILDING AND ANALYSIS
    Gsteiger, S.
    Windisch, R.
    Bryden, P.
    Wiksten, A.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A402 - A402
  • [2] Efficient estimation in a nonproportional hazards model
    Vonta, F
    [J]. LIFETIME DATA: MODELS IN RELIABILITY AND SURVIVAL ANALYSIS, 1996, : 347 - 351
  • [3] A network meta-analysis of updated haemostatic strategies for hysterectomy
    Guo, Tao
    Ren, Liang
    Wang, Quanxiong
    Li, Kun
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2016, 35 : 187 - 195
  • [4] Strategies for thromboprophylaxis in Fontan circulation: a network meta-analysis
    Van den Eyndel, J.
    Possner, M.
    Alahdab, F.
    Veldtman, G.
    Goldstein, B.
    Rathod, R.
    Hoskoppal, A.
    Saraf, A.
    Feingold, B.
    Alsaied, T.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 1831 - 1831
  • [5] Treatment strategies for Graves' ophthalmopathy: a network meta-analysis
    Zhou, Xiaoxin
    Zhou, Dongdong
    Wang, Juan
    Chen, Guangmin
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2020, 104 (04) : 551 - 556
  • [6] Efficient network meta-analysis: A confidence distribution approach
    Yang, Guang
    Liu, Dungang
    Liu, Regina Y.
    Xie, Minge
    Hoaglin, David C.
    [J]. STATISTICAL METHODOLOGY, 2014, 20 : 105 - 125
  • [7] A Comparison of Alternative Network Meta-Analysis Methods in the Presence of Nonproportional Hazards: A Case Study in First-Line Advanced or Metastatic Renal Cell Carcinoma
    Cope, Shannon
    Chan, Keith
    Campbell, Harlan
    Chen, Jenny
    Borrill, John
    May, Jessica R.
    Malcolm, William
    Branchoux, Sebastien
    Kupas, Katrin
    Jansen, Jeroen P.
    [J]. VALUE IN HEALTH, 2023, 26 (04) : 465 - 476
  • [8] Network meta-analysis
    White, Ian R.
    [J]. STATA JOURNAL, 2015, 15 (04): : 951 - 985
  • [9] Network meta-analysis
    De Laat, A.
    [J]. JOURNAL OF ORAL REHABILITATION, 2017, 44 (10) : 735 - 735
  • [10] Network Meta-analysis
    Cappelleri, Joseph C.
    Baker, William L.
    [J]. BIOPHARMACEUTICAL APPLIED STATISTICS SYMPOSIUM: BIOSTATISTICAL ANALYSIS OF CLINICAL TRIALS, VOL 2, 2018, : 91 - 105